Request Sample Inquiry
Point Of Care Diagnostics Market

Point of Care Diagnostics Market

Point of Care Diagnostics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

146

Base Year:

2022

Date

Aug - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1821

Segments Covered
  • By Product By Product Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology
  • By End Users By End Users Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 45.06 Billion
Revenue 2030Revenue 2030: USD 95.89 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.90%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Point of Care Diagnostics Market Segment Analysis

  • Point of Care Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation Testing
    • Fertility/Pregnancy
    • Infectious Disease
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug of Abuse (DOA) Testing
    • Urinalysis/Nephrology
  • Point of Care Diagnostics End Users Outlook (Revenue, USD Million, 2018 - 2030)
    • Clinics
    • Hospitals
    • Home
    • Assisted Living Healthcare Facilities
    • Laboratories
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Point of Care Diagnostics Market, by Product
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Urinalysis/Nephrology
      • North America Point of Care Diagnostics Market, by End Users
        • Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
      • U.S.
        • U.S. Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • U.S. Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Canada
        • Canada Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Canada Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Mexico
        • Mexico Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Mexico Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
    • Europe
      • Europe Point of Care Diagnostics Market, by Product
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Urinalysis/Nephrology
      • Europe Point of Care Diagnostics Market, by End Users
        • Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
      • U. K.
        • U.K. Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • U.K. Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • France
        • France Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • France Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Germany
        • Germany Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Germany Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Italy
        • Italy Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Italy Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Spain
        • Spain Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Spain Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Rest of Europe
        • Rest of Europe Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Rest of Europe Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
    • Asia Pacific
      • Asia Pacific Point of Care Diagnostics Market, by Product
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Urinalysis/Nephrology
      • Asia Pacific Point of Care Diagnostics Market, by End Users
        • Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
      • China
        • China Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • China Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Japan
        • Japan Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Japan Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Germany
        • Germany Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Germany Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • India
        • India Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • India Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • South Korea
        • South Korea Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • South Korea Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • South East Asia
        • South East Asia Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • South East Asia Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Rest of Asia Pacific
        • Rest of Asia Pacific Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Rest of Asia Pacific Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
    • Latin America
      • Latin America Point of Care Diagnostics Market, by Product
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Urinalysis/Nephrology
      • Latin America Point of Care Diagnostics Market, by End Users
        • Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
      • Brazil
        • Brazil Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Brazil Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Argentina
        • Argentina Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Argentina Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Rest of Latin America
        • Rest of Latin America Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Rest of Latin America Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
    • Middle East & Africa
      • Middle East & Africa Point of Care Diagnostics Market, by Product
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Urinalysis/Nephrology
      • Middle East & Africa Point of Care Diagnostics Market, by End Users
        • Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
      • GCC Countries
        • GCC Countries Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • GCC Countries Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • South Africa
        • South Africa Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • South Africa Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Point of Care Diagnostics Market, by Product
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Urinalysis/Nephrology
        • Rest of Middle East & Africa Point of Care Diagnostics Market, by End Users
          • Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
FAQ
Frequently Asked Question
  • The global Point of Care Diagnostics valued at USD 45.06 Billion in 2022 and is expected to reach USD 95.89 Billion in 2030 growing at a CAGR of 9.90%.

  • The prominent players in the market are F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies Inc., Nipro Corp., Spectral Medical Inc..

  • The market is project to grow at a CAGR of 9.90% between 2023 and 2030.

  • The driving factors of the Point of Care Diagnostics include

    • High prevalence of infectious diseases

  • North America was the leading regional segment of the Point of Care Diagnostics in 2022.